Flatiron's Vice President of Research Oncology shares industry requirements for diversity among clinical trial participants. Recent research conducted by Flatiron scientists and oncologists shows demonstrates that we still have work to do.
Other videos from this series:
-
Research Background: Trial eligibility criteria and diversity among patients with advanced NSCLC
-
Research Goal: Trial eligibility criteria and diversity among patients with advanced NSCLC
-
Research Methodology: Trial eligibility criteria and diversity among patients with advanced NSCLC
-
Research Findings: Trial eligibility criteria and diversity among patients with advanced NSCLC
-
Research Learnings: Trial eligibility criteria and diversity among patients with advanced NSCLC
-
Research Learnings: How can sponsors balance eligibilty criteria and diversity goals?
-
Research Learnings: Why is diversity in clinical trials, essential?
-
What can sponsors do to enable more diversity in clinical trial?
Learn more about our clinical research solutions
Interested in seeing how Flatiron is bridging the gap between care and research?
